2026 Global: Flow Diverters Market-Competitive Review (2032) report
Description
The 2026 Global: Flow Diverters Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Major players in the Flow Diverters Market include Medtronic plc, headquartered in Dublin, Ireland, whose Pipeline Embolization Device is widely adopted for complex intracranial aneurysms. Stryker Corporation, based in Kalamazoo, Michigan, United States, markets the Surpass Flow Diverter, a prominent alternative in many surgical centers. Acandis GmbH, headquartered in Aachen, Germany, offers the Derivo Flow Diverter with a reputation for conformability and deliverability. Balt Extrusion, headquartered in Montfoort, Netherlands, manufactures the Silk Flow Diverter, a well-established option in European neuroendovascular practice. Phenox Medical GmbH, based in Bochum, Germany, markets the p48 Flow Diverter and other neurovascular devices. Meril Life Sciences Pvt. Ltd., located in Vadodara, India, has expanded its flow-diverter portfolio to address the Asia-Pacific market. Terumo Corporation, anchored in Tokyo, Japan, owns MicroVention, which supplies flow-diverter concepts and broad neurovascular devices to global markets.
Occlutech, headquartered in Vienna, Austria, provides OccluFlow and related flow-diverter options designed for flexible delivery and radiopacity in diverse anatomic configurations. Jotec GmbH, based in Hechingen, Germany, develops neurovascular hardware including flow-diverter platforms used across European centers. Sequent Medical, headquartered in Santa Monica, California, introduced the WEB family of flow-disruption devices and, after its acquisition, contributed its technology to Stryker's neurovascular portfolio, broadening access to flow-diverter alternatives. Occlutech's lineage and regulatory progress in multiple jurisdictions underscore the growing acceptance of flow-diversion techniques, while Jotec's collaboration with hospitals helps optimize procedural workflows, and Sequent's legacy technologies continue to inform contemporary device development.
Together, these ten companies shape the Flow Diverters Market by driving innovation in deliverability, conformability, radiopacity, and safety profiles. Ongoing development focuses on improved navigation through tortuous intracranial pathways, higher pore densities for efficient flow diversion, and resheathable designs to enhance operator control. Regulatory approvals continue to expand the geographic footprint of flow diverters, with North American, European, and Asia-Pacific markets broadening access while reimbursement frameworks evolve. Clinically, randomized and registry data inform best-practice selection, influence post-deployment imaging protocols, and shape retreatment strategies. The competitive landscape remains heavily consolidated among these ten players, yet regional manufacturers and emerging Asian groups press for cost-effective solutions that preserve device performance. Market entrants increasingly pursue partnerships with imaging and device suppliers to streamline adoption, while incumbents leverage clinical evidence, global distribution, and post-market surveillance to sustain physician confidence. In addition, patent landscapes, exclusivity rights, and supplier negotiations will continue to shape the price and availability of these devices, making collaboration essential for hospitals seeking to balance patient access with procurement cost constraints. The evolving landscape emphasizes standardized data collection, multicenter partnerships, and harmonized regulatory pathways to accelerate patient outcomes.
Major players in the Flow Diverters Market include Medtronic plc, headquartered in Dublin, Ireland, whose Pipeline Embolization Device is widely adopted for complex intracranial aneurysms. Stryker Corporation, based in Kalamazoo, Michigan, United States, markets the Surpass Flow Diverter, a prominent alternative in many surgical centers. Acandis GmbH, headquartered in Aachen, Germany, offers the Derivo Flow Diverter with a reputation for conformability and deliverability. Balt Extrusion, headquartered in Montfoort, Netherlands, manufactures the Silk Flow Diverter, a well-established option in European neuroendovascular practice. Phenox Medical GmbH, based in Bochum, Germany, markets the p48 Flow Diverter and other neurovascular devices. Meril Life Sciences Pvt. Ltd., located in Vadodara, India, has expanded its flow-diverter portfolio to address the Asia-Pacific market. Terumo Corporation, anchored in Tokyo, Japan, owns MicroVention, which supplies flow-diverter concepts and broad neurovascular devices to global markets.
Occlutech, headquartered in Vienna, Austria, provides OccluFlow and related flow-diverter options designed for flexible delivery and radiopacity in diverse anatomic configurations. Jotec GmbH, based in Hechingen, Germany, develops neurovascular hardware including flow-diverter platforms used across European centers. Sequent Medical, headquartered in Santa Monica, California, introduced the WEB family of flow-disruption devices and, after its acquisition, contributed its technology to Stryker's neurovascular portfolio, broadening access to flow-diverter alternatives. Occlutech's lineage and regulatory progress in multiple jurisdictions underscore the growing acceptance of flow-diversion techniques, while Jotec's collaboration with hospitals helps optimize procedural workflows, and Sequent's legacy technologies continue to inform contemporary device development.
Together, these ten companies shape the Flow Diverters Market by driving innovation in deliverability, conformability, radiopacity, and safety profiles. Ongoing development focuses on improved navigation through tortuous intracranial pathways, higher pore densities for efficient flow diversion, and resheathable designs to enhance operator control. Regulatory approvals continue to expand the geographic footprint of flow diverters, with North American, European, and Asia-Pacific markets broadening access while reimbursement frameworks evolve. Clinically, randomized and registry data inform best-practice selection, influence post-deployment imaging protocols, and shape retreatment strategies. The competitive landscape remains heavily consolidated among these ten players, yet regional manufacturers and emerging Asian groups press for cost-effective solutions that preserve device performance. Market entrants increasingly pursue partnerships with imaging and device suppliers to streamline adoption, while incumbents leverage clinical evidence, global distribution, and post-market surveillance to sustain physician confidence. In addition, patent landscapes, exclusivity rights, and supplier negotiations will continue to shape the price and availability of these devices, making collaboration essential for hospitals seeking to balance patient access with procurement cost constraints. The evolving landscape emphasizes standardized data collection, multicenter partnerships, and harmonized regulatory pathways to accelerate patient outcomes.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
